TACROLIMUS Safety Questions, TACROLIMUS Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about TACROLIMUS. Our extensive database of TACROLIMUS adverse events and TACROLIMUS warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about TACROLIMUS
TACROLIMUS Safety Reports
Total TACROLIMUS reports: 260.TACROLIMUS FDA safety alerts: 2003 2005 2006 .
Reported deaths: 93 Reported hospitalizations: 156.
Take TACROLIMUS Side Effects Survey or Share Your TACROLIMUS Story. Read More Here.
Showing 1-75 of 260 Next >
Physician from JAPAN reported TACROLIMUS problem on Mar 29, 2007. Female patient, 76 years of age, weighting 106.3 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: adjustment disorder, femur fracture, pyelonephritis. TACROLIMUS dosage: 1 MG, D, ORAL. During the same period patient was treated with PREDNISOLONE, CALONAL, MAGMITT, GASLON, CRAVIT, GASMOTIN, MEILAX, TETRAMIDE. Patient was hospitalized. Patient recovered.TACROLIMUS problem was reported by a Health Professional from UNITED KINGDOM on Apr 17, 2007. Male patient, 59 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: angiodysplasia, anxiety, cerebral atrophy, convulsion, diarrhoea, eosinophilia, febrile neutropenia, human herpesvirus 8 infection, liver transplant rejection. TACROLIMUS dosage: 3.00 MG, UID/QD, ORAL. During the same period patient was treated with PREDNISONE, METHYLPREDNISOLONE, INSULIN, MORPHINE, PANTOPRAZOLE, RAPAMYCIN, PIPERACILLIN, TAZOBACTAM. Patient was hospitalized. Patient died on 09/15/2005.
Health Professional from UNITED STATES reported TACROLIMUS problem on Apr 19, 2007. Male patient, 67 years of age, was diagnosed with renal transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bk virus infection, cardiac arrest, cardiomegaly, chest pain, cholecystitis acute, chronic allograft nephropathy, gallbladder disorder, haematocrit decreased, haematuria. TACROLIMUS dosage: 1.00 MG, BID; ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, SIROLIMUS, INSULIN, ZOCOR, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 05/26/2005.
TACROLIMUS problem was reported by a Health Professional from BELGIUM on Apr 20, 2007. Male patient, 62 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: aphasia, cerebral infarction, cerebral ischaemia, cerebrovascular accident, hemianopia, hemiparesis, incorrect dose administered, subarachnoid haemorrhage. TACROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, PARACETAMOL, FUROSEMIDE, DUOVENT. Patient was hospitalized and became disabled. Patient recovered.
Health Professional from FRANCE reported TACROLIMUS problem on Apr 26, 2007. Female patient, 53 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: conjunctival haemorrhage, escherichia urinary tract infection, face oedema, hepatitis, hypoalbuminaemia, hyponatraemia, skin haemorrhage. TACROLIMUS dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, PREDNISONE, PIPERILLINE, HEPARIN, FRAXIPARINE, ASPEGIC, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Health Professional from BELGIUM on Apr 26, 2007. Female patient, 49 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, congenital cystic kidney disease, dialysis, renal impairment. TACROLIMUS dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, DACLIZUMAB, METHYLPREDNISOLONE, AMPICILLIN, CEFOTAXIME, TOBRAMYCIN. Patient was hospitalized. Patient recovered.
Health Professional from FRANCE reported TACROLIMUS problem on Apr 27, 2007. Female patient, 40 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: haemoglobin decreased, peritoneal haemorrhage, sepsis. TACROLIMUS dosage: 3 MG, UID/QD; ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TAZOCILLINE, AMPHOTERICIN B, COLISTIN, GANCICLOVIR. Patient recovered.
TACROLIMUS problem was reported by a Physician from BELGIUM on May 21, 2007. Male patient, weighting 149.9 lb, was diagnosed with prophylaxis against transplant rejection, diabetes mellitus and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: ascites. TACROLIMUS dosage: unknown. During the same period patient was treated with INSULATARD, ZOVIRAX, BACTRIM DS. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported TACROLIMUS problem on May 04, 2007. Male patient, 56 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, bronchopulmonary aspergillosis, fungal infection, pneumonia, tracheal disorder, tracheal ulcer. TACROLIMUS dosage: 3 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, DACLIZUMAB, PREDNISOLONE, FUROSEMIDE, INSULIN, PANTOPRAZOLE, MEROPENEM. Patient was hospitalized. Patient died on 12/27/2005.
TACROLIMUS problem was reported by a Physician from UNITED KINGDOM on Apr 30, 2007. Male patient, 64 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: ascites, autoimmune hepatitis, blood bilirubin increased, cough, disease recurrence, haemothorax, hepatic enzyme increased. TACROLIMUS dosage: 4 MG, UID/QD, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, PREDNISONE, BUDESONIDE, INSULIN, ESOMEPRAZOLE, FUROSEMIDE. Patient was hospitalized. Patient died on 09/25/2005.
Health Professional from BELGIUM reported TACROLIMUS problem on Apr 30, 2007. Female patient, 49 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: congenital cystic kidney disease, dialysis, renal impairment. TACROLIMUS dosage: 2 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, DACLIZUMAB, METHYLPREDNISOLONE, AMPICILLIN, CEFOTAXIME, TOBRAMYCIN. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Physician from CANADA on May 17, 2007. Female patient, weighting 207.2 lb, was diagnosed with renal transplant, hypertension, prophylaxis, diabetes mellitus and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: arrhythmia, herpes zoster, implant site effusion, streptococcal infection, urinary tract infection bacterial. TACROLIMUS dosage: unknown. During the same period patient was treated with CELLCEPT, METOPROLOL SUCCINATE, AMLODIPINE, PANTOPRAZOLE, NOVORAPID, HUMULIN N, PREDNISONE. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported TACROLIMUS problem on May 14, 2007. Female patient, weighting 125.7 lb, was diagnosed with prophylaxis against transplant rejection, hypertension, renal impairment, diabetes mellitus, prophylaxis against gastrointestinal ulcer and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: hypertensive crisis. TACROLIMUS dosage: unknown. During the same period patient was treated with PREDNISOLONE, CLONIDINE, HYDROCHLOROTHIAZIDE, INSULIN ECTION, MYCOPHENOLATE MOFETIL, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Male patient, child 5 years of age, was diagnosed with dermatitis atopic and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: pneumonia. TACROLIMUS dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported TACROLIMUS problem on May 11, 2007. Female patient, 46 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: hepatorenal syndrome. TACROLIMUS dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, TRIMETHOPRIM. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on Apr 14, 2007. Female patient, 50 years of age, weighting 119.0 lb, was diagnosed with myasthenia gravis, rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: angiopathy, blood cholesterol increased, blood urea decreased, cerebral infarction, folliculitis, hemiplegia, low density lipoprotein increased, nasopharyngitis. TACROLIMUS dosage: 2 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, MEDROL, MESTINON, ASPARA, ALOSITOLLET. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported TACROLIMUS problem on May 17, 2007. Female patient, child 2 years of age, was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: parainfluenzae virus infection, pneumonia, pneumonia parainfluenzae viral, varicella. TACROLIMUS dosage: unknown. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Health Professional from UNITED STATES on May 14, 2007. Female patient, 63 years of age, weighting 196.0 lb, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: aspergillosis, candidiasis, diabetes mellitus inadequate control, dizziness, enterococcal infection, haemoptysis, headache, hepatomegaly, metastases to liver. TACROLIMUS dosage: unknown. During the same period patient was treated with DILTIAZEM, POTASSIUM CHLORIDE, ESOMEPRAZOLE, INSULIN ASPART, HYDROCODONE W, FLEET ENEMA, PROMETHAZINE, MORPHINE SULPHATE. Patient died on 03/13/2007.
Physician from JAPAN reported TACROLIMUS problem on May 14, 2007. Male patient, 78 years of age, weighting 145.5 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood triglycerides increased, blood urea increased, spinal compression fracture, white blood cell count increased. TACROLIMUS dosage: unknown. During the same period patient was treated with PREDNISOLONE, ETODOLAC, SELBEX, RISEDRONATE. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Health Professional from UNITED KINGDOM on May 14, 2007. Male patient, 54 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal sepsis, blood pressure diastolic decreased, collapse of lung, continuous haemodiafiltration, enterococcal infection, haemorrhage. TACROLIMUS dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, HYDROCORTISONE, PREDNISOLONE, PROPOFOL, AMITRIPTYLINE, LANSOPRAZOLE, PARACETAMOL. Patient was hospitalized. Patient died on 06/02/2005.
Health Professional from UNITED KINGDOM reported TACROLIMUS problem on May 10, 2007. Female patient, 44 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal sepsis, ascites infection, atrial fibrillation, blood albumin decreased, blood culture positive, blood product transfusion dependent, cellulitis, diarrhoea, enterococcal infection. TACROLIMUS dosage: 2.00 MG, UID/QD, ORAL. During the same period patient was treated with DACLIZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, HYDROCORTISONE, PREDNISONE, PIPERACILLIN AND TAZOBACTAM, FLUCONAZOLE, CALCIUM CHLORIDE. Patient was hospitalized and became disabled. Patient died on 06/14/2005.
TACROLIMUS problem was reported by a Health Professional from GERMANY on May 18, 2007. Male patient, 58 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal infection, abdominal sepsis, aspiration tracheal abnormal, bone marrow failure, candidiasis, cholestasis, continuous haemodiafiltration, convulsion, enterococcal infection. TACROLIMUS dosage: 3 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, PREDNISONE, ANTITHROMBIN II, TRIMETHOPRIM, CALCIUM CHLORIDE, CILASTATIN W. Patient was hospitalized. Patient died on 09/07/2005.
Health Professional from GERMANY reported TACROLIMUS problem on May 18, 2007. Female patient, 59 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal infection, aspergillosis, bone marrow failure, candidiasis, enterococcal infection, haematoma infection, hepatic failure, multi-organ failure, post procedural complication. TACROLIMUS dosage: 0.5 MG, UID/QD, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, DACLIZUMAB, METHYLPRENISOLONE, PREDNISONE, HYDROCORTISONE, NOREPINEPHRINE HYDROCHLORIDE, ANTITHROMBIN III, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient died on 09/28/2005.
TACROLIMUS problem was reported by a Physician from FRANCE on May 17, 2007. Male patient, 44 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: asthenia, gingivitis, herpes virus infection, kaposi's sarcoma, lymphadenopathy, weight decreased. TACROLIMUS dosage: 3 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, DACLIZUMAB, METHYLPREDNISOLONE, PIPERILLINE, ZOVIRAX, HEPARIN, VALACYCLOVIR. Patient recovered.
Health Professional from UNITED KINGDOM reported TACROLIMUS problem on May 27, 2007. Male patient, 67 years of age, was diagnosed with renal transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bk virus infection, cardiac arrest, cardiomegaly, cholecystitis acute, haematuria, hypertensive emergency, pneumonia, post procedural complication. TACROLIMUS dosage: 1.00 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, SIROLIMUS, INSULIN, ZOCOR, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 05/26/2005.
TACROLIMUS problem was reported by a Physician from JAPAN on May 30, 2007. Male patient, 53 years of age, weighting 143.3 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. TACROLIMUS dosage: 1 MG, UID/QD, ORAL. During the same period patient was treated with PREDNISOLONE, AZULFIDINE EN, TICLOPIDINE, CALTAN, LANSOPRAZOLE, ADALATLET, SEVELAMER HYDROCHLORIDE, BARACLUDELET. Patient died on 03/26/2007.
Physician from JAPAN reported TACROLIMUS problem on May 28, 2007. Male patient, 68 years of age, weighting 145.5 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, culture positive, osteomyelitis bacterial, staphylococcal infection. TACROLIMUS dosage: unknown. During the same period patient was treated with PREDNISOLONE, VOLTAREN, INDACIN, GLYCOL SALICYLATE, LANSOPRAZOLE. Patient recovered.
TACROLIMUS problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 27, 2007. Male patient, child 5 years of age, was diagnosed with dermatitis atopic and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: pneumonia. TACROLIMUS dosage: unknown. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported TACROLIMUS problem on May 27, 2007. Male patient, 53 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: cardiac failure, complications of transplanted liver, continuous haemodiafiltration, enterococcal infection, gastric perforation, hepatic failure, hyperglycaemia, large intestine perforation. TACROLIMUS dosage: 4.00 MG, BID, IV BOLUS. During the same period patient was treated with METHYLPREDNISOLONE, ARTERENOL, MYCOPHENOLATE MOFETIL, HYDROCORTISONE, ANTIBIOTICS, MERONEM, CIPROFLOXACIN. Patient was hospitalized and became disabled. Patient died on 09/07/2004.
TACROLIMUS problem was reported by a Physician from JAPAN on June 06, 2007. Female patient, 75 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, haematemesis. TACROLIMUS dosage: 1 MG, D, ORAL. During the same period patient was treated with PREDNISOLONE, OLMETEC, HYPOCA, GASTER. Patient was hospitalized. Patient recovered.
Physician from GERMANY reported TACROLIMUS problem on May 31, 2007. Male patient, 50 years of age, weighting 183.0 lb, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: retinal vein occlusion, retinitis, venous thrombosis. TACROLIMUS dosage: 17 MG, D, ORAL. During the same period patient was treated with SIMULECT. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Health Professional from SPAIN on June 04, 2007. Male patient, 59 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: angiodysplasia, human herpesvirus 8 infection, liver transplant rejection, meningitis cryptococcal, multi-organ failure, primary effusion lymphoma, rectal haemorrhage. TACROLIMUS dosage: 3.00 MG, UID/QD, ORAL. During the same period patient was treated with PREDNISONE, METHYLPREDNISOLONE, INSULIN, MORPHINE, PANTOPRAZOLE, RAPAMYCIN, PIPERACILLIN, TAZOBACTAM. Patient was hospitalized. Patient died on 09/15/2005.
Physician from JAPAN reported TACROLIMUS problem on May 31, 2007. Female patient, weighting 75.84 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bacteraemia, blood glucose increased, blood pressure increased. TACROLIMUS dosage: 1.5 MG, /D, ORAL. During the same period patient was treated with PREDNISOLONE, LOXONIN, TAKEPRON, KAMAG G, DIOVAN, PRAVASTATIN, ONEALFA, PAXIL. Patient died on 04/03/2007.
TACROLIMUS problem was reported by a Physician from JAPAN on June 11, 2007. Female patient was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: pneumonia. TACROLIMUS dosage: unknown. Patient died.
Physician from JAPAN reported TACROLIMUS problem on June 07, 2007. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis, lumbar spinal stenosis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: aspartate aminotransferase increased, bronchitis, haemoptysis, haemorrhagic diathesis, infection in an immunocompromised host, lung disorder. TACROLIMUS dosage: 1.5 MG, UID/QD, ORAL. During the same period patient was treated with PREDNISOLONE, OPALMON, VOLTAREN, AZULFIDINE ENLET, ROXATIDINE ACETATE, BERIZYM, MUCOSTA. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on June 07, 2007. Female patient, 80 years of age, weighting 81.35 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: anaemia, angina pectoris, fall, gastric ulcer haemorrhage, muscular weakness, pain, stress. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, VOLTAREN, PREDNISOLONE, METHOTREXATE. Patient recovered.
Physician from UNITED KINGDOM reported TACROLIMUS problem on June 06, 2007. Female patient, child 2 years of age, weighting 26.46 lb, was diagnosed with psoriasis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: pneumonia parainfluenzae viral, sepsis, varicella. TACROLIMUS dosage: unknown. During the same period patient was treated with DERMOL, CETRABEN. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on June 12, 2007. Female patient, 85 years of age, weighting 83.56 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: fall, femur fracture, myocardial infarction. TACROLIMUS dosage: 1.5 MG, ORAL. During the same period patient was treated with METHYLPREDNISOLONE, MOBIC, ISONIAZID, SELBEX. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported TACROLIMUS problem on June 11, 2007. Female patient, 52 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest, cardiac failure, cerebral atrophy, convulsion, pathogen resistance, septic shock, staphylococcal sepsis. TACROLIMUS dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, INSULIN, FUROSEMIDE, BLOOD AND RELATED PRODUCTS, ALBUMIN. Patient died on 08/10/2005.
TACROLIMUS problem was reported by a Health Professional from UNITED KINGDOM on June 15, 2007. Male patient, 58 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal infection, aspiration tracheal abnormal, asthenia, bone marrow failure, candidiasis, cerebral haemorrhage, continuous haemodiafiltration, convulsion, enterococcal infection. TACROLIMUS dosage: 3 MG, BID, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, PREDNISONE, ANTITHROMBIN II, TRIMETHOPRIM, CALCIUM, CILASTIN W, METAMIZOLE. Patient was hospitalized. Patient died on 09/07/2005.
Health Professional from JAPAN reported TACROLIMUS problem on June 12, 2007. Female patient, 51 years of age, weighting 154.5 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: cellulitis, hepatic function abnormal, oedema peripheral, pain in extremity, thrombophlebitis. TACROLIMUS dosage: unknown. During the same period patient was treated with RHEUMATREX, FOLIAMIN, VOLTAREN, SOLON, LIDOCAINE, KENACORT, INTEBAN, RINDERON. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Physician from UNITED STATES on June 22, 2007. Male patient, weighting 129.1 lb, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: kidney transplant rejection. TACROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, ZENAPAX. Patient recovered.
Health Professional from UNITED KINGDOM reported TACROLIMUS problem on June 18, 2007. Female patient, 59 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal infection, aspergillosis, blood bilirubin increased, bone marrow failure, candidiasis, cholestasis, complications of transplanted liver, enterococcal infection, fungal sepsis. TACROLIMUS dosage: 4 MG, UID/QD, ORAL. During the same period patient was treated with MYCOPHENOLATE MOFETIL, DACLIZUMAB, METHYLPREDNISOLONE, PREDNISONE, HYDROCORTISONE, NOREPINEPHRINE HYDROCHLORIDE, ANTITHROMBIN III, SULFAMETHOXAZOLE AND TRIMETHOPRIM. Patient was hospitalized. Patient died on 09/28/2005.
TACROLIMUS problem was reported by a Physician from JAPAN on June 18, 2007. Female patient, 51 years of age, weighting 154.5 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: cellulitis, deep vein thrombosis, oedema peripheral, pain in extremity. TACROLIMUS dosage: 3 MG, D, ORAL. During the same period patient was treated with RHEUMATREX, FOLIC ACID, VOLTAREN, SOLON, LIDOCAINE, KENACORT, INDOMETHACIN, RINDERON. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported TACROLIMUS problem on June 29, 2006. Female patient, 31 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: arteriovenous fistula, asthenia, dehydration, diarrhoea, escherichia urinary tract infection, pollakiuria, pyelonephritis acute, renal failure. TACROLIMUS dosage: unknown. During the same period patient was treated with APROVEL, CELLCEPT, CORTANCYL, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on June 27, 2006. Female patient, 82 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: arthralgia, joint swelling, nasopharyngitis, oxygen saturation decreased, pneumocystis jiroveci pneumonia, pneumonia bacterial. TACROLIMUS dosage: 1.5 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, PREDNISOLONE, MUCOSTA, MOBIC, RISEDRONATE, HEAVY KAMA G, CALBLOCK. Patient died on 02/26/2006.
Health Professional from FRANCE reported TACROLIMUS problem on June 23, 2006. Female patient, 64 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: peritoneal effusion. TACROLIMUS dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with ZENAPAX, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE, PREDNISONE, ZOVIRAX, VALACYCLOVIR, BACTRIM. Patient recovered.
TACROLIMUS problem was reported by a Pharmacist from UNITED STATES on July 13, 2006. Female patient was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: fluid intake reduced, gastroenteritis viral, malaise, mental status changes, pancreatitis acute. TACROLIMUS dosage: 8 MG 2 X/D PO. During the same period patient was treated with PREDNISONE, VALGANCICLOVIR, MYCOPHENOLATE MOFETIL, COTRIMOXAZOLE, ATENOLOL, LUNESTA, AMLODIPINE. Patient recovered.
Physician from JAPAN reported TACROLIMUS problem on June 29, 2006. Female patient, 69 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: sepsis. TACROLIMUS dosage: 1 MG, ORAL. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, MOBIC, MUCOSTA, ONEALFA, PANALDINE, BAYASPIRIN PER ORAL NOS. Patient died on 04/18/2006.
TACROLIMUS problem was reported by a Physician from JAPAN on June 26, 2006. Male patient, 73 years of age, weighting 119.0 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: lumbar vertebral fracture, pneumonia bacterial. TACROLIMUS dosage: 2 MG, D, ORAL. During the same period patient was treated with PREDNISOLONE, ENBREL. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TACROLIMUS problem on July 05, 2006. Male patient, 64 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pneumocystis jiroveci pneumonia. TACROLIMUS dosage: 2 MG, D, ORAL; 3 MG, D, ORAL. During the same period patient was treated with TACROLIMUS CAPSULES, PREDNISOLONE, GASTER PER ORAL NOS, MOBIC, NORVASC, LOXONIN, LIPITOR, OMEPRAZON. Patient died on 07/05/2006.
TACROLIMUS problem was reported by a Physician from JAPAN on June 29, 2006. Female patient, 25 years of age, weighting 72.75 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, depression, mental disorder, persecutory delusion, suicide attempt, vomiting. TACROLIMUS dosage: 1 MG, UID/QD, ORAL; 2 MG UID/QD, ORAL; 54 DF D, ORAL. During the same period patient was treated with TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, RHEUMATREX, VOLTAREN, LENDORMIN, PREDNISOLONE, RIMATIL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from MEXICO reported TACROLIMUS problem on July 06, 2006. Female patient, 16 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, kidney transplant rejection. TACROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, VERAPAMIL. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Consumer or non-health professional from GERMANY on July 10, 2006. Female patient, 56 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, transplant rejection. TACROLIMUS dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported TACROLIMUS problem on July 14, 2006. Female patient, 35 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: abdominal pain, chest pain, computerised tomogram abdomen abnormal, condition aggravated, hypertension, nausea, oesophagitis, tachycardia, vomiting. TACROLIMUS dosage: 2 MG 2X PER 1 DAY, ORAL; SEE IMAGE. During the same period patient was treated with CELLCEPT, PREDNISONE, ZENAPAX, CLONIDINE. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on July 18, 2006. Male patient, 64 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, immunosuppression, interstitial lung disease, pneumocystis jiroveci pneumonia, respiratory failure. TACROLIMUS dosage: 2 MG ORAL. During the same period patient was treated with PREDNISOLONE, GASTER, MOBIC, NORVASC, LOXONIN, LIPITOR, OMEPRAZOLE, PROMAC. Patient died on 07/05/2006.
Physician from JAPAN reported TACROLIMUS problem on July 27, 2006. Male patient, 64 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, interstitial lung disease, pneumocystis jiroveci pneumonia, respiratory failure. TACROLIMUS dosage: 2 MG, D, ORAL; 3 MG, D, ORAL. During the same period patient was treated with TACROLIMUS CAPSULES, PREDNISOLONE, GASTER, MOBIC, NORVASC, LOXONIN, LIPITOR, OMEPRAZOLE. Patient died on 07/05/2006.
TACROLIMUS problem was reported by a Physician from UNITED KINGDOM on July 28, 2006. Male patient, 64 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, cardiac arrest, lung infection pseudomonal. TACROLIMUS dosage: 3 MG, UID/QD, ORAL. During the same period patient was treated with ZENAPAX, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TACROLIMUS problem on July 31, 2006. Male patient, 50 years of age, weighting 134.5 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: thrombophlebitis. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, PREDNISOLONE. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on Aug 09, 2006. Female patient, 69 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: sepsis. TACROLIMUS dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, MOBIC, MUCOSTA, ONEALFA, TICLOPIDINE, BAYASPIRINE. Patient died on 04/18/2006.
Physician from JAPAN reported TACROLIMUS problem on Aug 10, 2006. Female patient, 72 years of age, weighting 111.3 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, diabetes mellitus, dyskinesia, fall, fracture, haemorrhage, platelet count decreased, tremor. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, PREDNISOLONE, LOXOPROFEN, VOLTAREN. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Pharmacist from UNITED STATES on Aug 31, 2006. Female patient, 13 years of age, was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: tremor. TACROLIMUS dosage: unknown. Patient recovered.
Physician from JAPAN reported TACROLIMUS problem on Aug 21, 2006. Male patient, 73 years of age, weighting 119.0 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: lumbar vertebral fracture, pathological fracture, pneumonia bacterial. TACROLIMUS dosage: 2 MG, ORAL. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized and became disabled. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on Aug 21, 2006. Female patient, weighting 110.2 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, decubitus ulcer. TACROLIMUS dosage: 1 MG, ORAL; SEE IMAGE. During the same period patient was treated with TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, PREDNISOLONE, VOLTAREN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TACROLIMUS problem on Aug 25, 2006. Male patient, 80 years of age, weighting 135.6 lb, was diagnosed with myasthenia gravis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: infection, pneumonia. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, PREDNISOLONE, MESTINON, LANSOPRAZOLE, NEUROTROPIN, DIART. Patient died.
TACROLIMUS problem was reported by a Physician from JAPAN on Aug 25, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, haemorrhagic cerebral infarction, loss of consciousness, stress ulcer. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, PREDNISOLONE, AZULFIDINE, MOBIC, ALFAROL, VOLTAREN. Patient died on 08/23/2006.
Physician from JAPAN reported TACROLIMUS problem on Aug 22, 2006. Female patient, 76 years of age, weighting 106.3 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: adjustment disorder, pyelonephritis. TACROLIMUS dosage: unknown. During the same period patient was treated with PREDNISOLONE, CALONAL, MAGMITT, GASLON, LEVOFLOXACIN, GASMOTIN, MEILAX, TETRAMIDE. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on Sept 04, 2006. Female patient, 74 years of age, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood pressure systolic increased, condition aggravated, interstitial lung disease, lower respiratory tract infection bacterial, lower respiratory tract infection fungal, lung disorder, pneumocystis jiroveci infection, pulmonary tuberculosis. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, METALCAPTASE CAPSULE, PREDNISOLONE, LOXONIN, CLINORIL, MUCOSTA, AMARYL. Patient died on 08/13/2006.
Pharmacist from UNITED KINGDOM reported TACROLIMUS problem on Sept 01, 2006. Female patient, 16 years of age, weighting 94.80 lb, was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: biliary tract disorder, c-reactive protein increased, gallbladder non-functioning, pyrexia. TACROLIMUS dosage: 2 MG, BID, ORAL. During the same period patient was treated with AZATHIOPRINE, METHYLPREDNISOLONE, SUCRALFATE. Patient was hospitalized. Patient recovered.
TACROLIMUS problem was reported by a Physician from JAPAN on Aug 30, 2006. Female patient, weighting 110.2 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, decubitus ulcer, staphylococcal infection, suture related complication. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, TACROLIMUS CAPSULES, PREDNISOLONE, VOLTAREN, VANCOMYCIN, HABEKACIN. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TACROLIMUS problem on Sept 06, 2006. Female patient, 64 years of age, weighting 81.57 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: haemorrhagic cerebral infarction, loss of consciousness, pneumonia bacterial, stress ulcer. TACROLIMUS dosage: unknown. During the same period patient was treated with TACROLIMUS CAPSULES, PREDNISOLONE, AZULFIDINE, MOBIC, VOLTAREN, ALFAROL, WARFARIN. Patient was hospitalized. Patient died on 08/23/2006.
TACROLIMUS problem was reported by a Consumer or non-health professional from ARGENTINA on Sept 07, 2006. Female patient, 23 years of age, was diagnosed with prophylaxis against transplant rejection and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: anaemia, gastrointestinal stromal tumour, immunosuppression, renal atrophy. TACROLIMUS dosage: 1MG 1X PER 12 HR. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, ACYCLOVIR, LOSARTAN POTASSIUM, ATORVASTATIN CALCIUM. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported TACROLIMUS problem on Sept 08, 2006. Female patient, 64 years of age, weighting 108.0 lb, was diagnosed with rheumatoid arthritis and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. TACROLIMUS dosage: 1.5 MG, UID/QD, ORAL. During the same period patient was treated with RHEUMATREX, PREDNISOLONE, KETOPROFEN SUPPOSITORY, DICLOFENAC, GAMOFA ORODISPERSABLE CRLET, CYTOTEC, ALFACALCIDOL, ACTONEL. Patient died on 08/14/2006.
TACROLIMUS problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 21, 2006. Male patient, 57 years of age, weighting 206.1 lb, was diagnosed with renal disorder, atrial fibrillation and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: asthenia, hypotension, reversible posterior leukoencephalopathy syndrome, tremor. TACROLIMUS dosage: 0.5 MG PO BID. During the same period patient was treated with AMIODARONE, WARFARIN, GABAPENTIN, LOSARTAN POSTASSIUM, PRAVASTATIN, ALLOPURINOL, TRAZODONE, FOLIC ACID. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported TACROLIMUS problem on Sept 21, 2006. Male patient, 21 years of age, weighting 183.0 lb, was diagnosed with renal transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hypertension, thrombotic microangiopathy. TACROLIMUS dosage: 8 MG PO BID. During the same period patient was treated with MYCOPHENOLATE MOFETIL, PREDNISONE, ACYCLOVIR, SULFAMETHOXAZOLE, CLONIDINE, NIFEDIPINE. Patient was hospitalized. Patient recovered.
Showing 1-75 of 260 Next >
This
drug has an active FDA Safety Alert